|Download document||Draft guideline on similar biological medicinal products|
|Reference number||CHMP/437/04 Rev. 1|
|Status||draft: consultation closed|
This guideline outlines the general principles to be applied for similar biological medicinal products (also known as biosimilars). It describes and addresses the application of the biosimilar approach, the choice of the reference product and the principles of establishing biosimilarity.